Cannabis News

Battle lines being drawn as petition to decriminalize marijuana in Killeen moves to City Council – Cannabis Business Executive


Next week, the House of Representatives is expected to vote on a bill that would effectively decriminalize and suppress cannabis, marking only the second time in more than 50 years that a house of Congress has voted to reclassify cannabis from its current status. federally banned substance. What can we expect in terms of timelines and expected results?

The MORE Act has been in the works since 2019, but for various reasons has not progressed each time it has been introduced in Congress. Even though the bill dies again this time around, it seems that with each pass each year, we are getting closer and closer to some level of reasonable cannabis regulation. Whatever happens with the bill this time around, we’ll keep you posted every step of the way. In the meantime, stay up to date important event in the industry by subscribing to the THC Weekly Bulletin. Plus, it’ll give you insider access to deals on cannabis flowers, vapes, edibles, and more! We also have great deals on cannabinoids, like HHC-O, delta 8, Delta 9 THC, Delta-10 THC, THCO, THCV, THCP & HHC, which won’t kill your bank account. Head to our “Best-of” lists to get these deals, and don’t forget to take advantage of them responsibly!


Next indoor vote

Members of the United States House of Representatives just announced yesterday that they will hold a floor vote next week on Marijuana Opportunity, Reinvestment, and Clearance Act (MORE), or HR 3617. Many publications describe this as a “federal legalization bill”. Essentially, that’s true, but technically, it’s not. According to the opening text of HR 3617, the purpose of this bill is to “decriminalize and declassify cannabis, provide for reinvestment in certain people affected by the war on drugs, provide for expungement of certain related offenses cannabis and for other purposes. .”

The terms “decriminalization” and “legalization” are often used interchangeably, but there are key differences between the two. Decriminalization officially removes criminal penalties for certain crimes, but civil penalties such as fines and forced rehabilitation could still apply. Under such a mandate, individual states could make their own decisions on whether to open up local cannabis markets or restrict them further. In short, the bill gives states even more latitude and performs a 180-degree turn on existing policy, declaring that cannabis is in fact NOT dangerous, and IS IT THAT have medicinal value (something advocates and consumers have been saying for decades).

In addition, this bill would ensure that people with previous cannabis crime convictions are no longer barred from obtaining business licenses. The Small Business Administration would create the Cannabis Restorative Opportunity Program, which would provide all necessary assistance to businesses owned and operated by “socially and economically disadvantaged individuals.” HR 3617 would also prevent the federal government from denying benefits, housing, and social services to cannabis users, as has been the case in the past.

Now, we already know that if this bill passes, the prosecution of “cannabis-related” crimes will immediately become a distant memory (reinvestment and expungement); and because no sane judge would sentence someone to a cannabis treatment center (especially considering we have much more pressing addiction issues to deal with); and because the bill introduces a 5% tax on cannabis products and promotes legal sales; it is safe to say that in this scenario, the difference between decriminalization and legalization is negligible.

The last time the MORE Act was introduced was in December 2020. It passed by 228 votes to 164, with only five Republicans joining their fellow Democrats in pushing the reform forward. The bill subsequently failed and was not heard in the Senate.

The time of changes

Consumers and industry experts all agree it’s time for a change. “Advancing this legislation to delist marijuana and help the individuals and communities who have borne the brunt of the failure of U.S. prohibition is critical,” said NORML Policy Director Morgan Fox. “More than two-thirds of Americans support the repeal of the federal marijuana ban and they deserve to know where our elected officials stand on this issue.

Maritza Perez, director of the Drug Policy Alliance’s national affairs office, said the bill is an opportunity to move beyond decades of racially unjust cannabis prohibition laws and the consequences of such enforcement. “For more than half a century, marijuana prohibition has been the cornerstone of the cruel and inhuman drug war that has deprived millions of their freedom and livelihood. Whose weight has fallen disproportionately on the backs of black, Latinx, indigenous and low-income communities – who remain his number one target,” she said.

“They have been denied jobs, housing, educational opportunities and much more. Their families were torn apart. Others have lost their immigration status. And our communities have suffered badly. Passing the legislation will help “ensure that our communities are not put on the back burner and forced to wait a moment longer for long overdue justice”, she added.

more act

Justin Strekal, founder of the pro-legalization political action committee BOWL PAC, also made an interesting point, saying the floor vote result will help voters better understand their lawmakers’ views on cannabis, and so , will allow them to vote accordingly.

“For the first time in history, Americans will be able to go to the polls knowing whether or not their representative voted to end prohibition or maintain the racist and senseless policy of criminalizing marijuana,” he said. he declares. “Now is the time for lawmakers to ask the question: Do I want to vote against the will of the super majority of American voters?

What about the Senate bill that just passed?

Seemingly under cover of obscurity, the Senate passed a completely different cannabis bill on Thursday. This bipartisan legislation will ease restrictions in the science sector. This would streamline the application process for researchers who want to conduct cannabis studies and trials, and encourage the Food and Drug Administration (FDA) to use that research and develop more cannabis-derived drugs.

“Current rules and regulations make it difficult for researchers to study how marijuana and marijuana-derived drugs can best be used to treat various conditions,” CA Senator Dianne Feinstein said in a press release. “This important legislation will cut red tape around the research process, helping to safely provide patients with FDA-approved marijuana-derived drugs.”

Chuck Grassley (R-IA), a co-sponsor of the bill, said the legislation “is essential to better understand the marijuana plant and its potential benefits and side effects.” He added, “This will allow the FDA to test CBD and medical marijuana products in a safe and responsible manner so that the American public can decide whether to use them in the future based on sound science.” , did he declare. “Marijuana research is widely supported by my colleagues on both sides of the aisle, and it’s a smart step forward in combating this current drug agenda.”

Conclusion

It is undeniably a very exciting time to be a stoner. A few decades ago, the idea of ​​federal cannabis legalization was about as far-fetched as political ideology can get. But now it looks like the MORE Act is gaining traction and decriminalization doesn’t seem that far off. Even if HR 3617 doesn’t pass next week, or pass the Senate again, we can be sure that a bill of this nature will be pass soon, finally ending our restrictive and absurd prohibition laws.

Hello and welcome! You’ve arrived at CBDtesters.co, the #1 website for the most comprehensive independent news coverage in the cannabis and psychedelics Industries. Join us as soon as possible to stay up to date with the ever-changing landscape of cannabis and psychedelics, and subscribe to The weekly THC newsletterso you are always aware of what is going on.

Disclaimer: Hello, I am a researcher and writer. I am neither a doctor, nor a lawyer, nor a businessman. All information in my articles is sourced and referenced, and all opinions expressed are my own. I do not give advice to anyone, and while I am more than happy to discuss topics, if anyone has another question or concern they should seek advice from a competent professional.





#Battle #lines #drawn #petition #decriminalize #marijuana #Killeen #moves #City #Council #Cannabis #Business #Executive

Related Posts

Leave a Reply